Gisela Robles Aguilar
Global Burden of Disease Researcher
Gisela joined GRAM as a Global Burden of Disease Researcher in 2018, and she supports efforts to estimate the burden of antimicrobial resistance worldwide and inform public health decision-making at the local and international levels. In the last three years, Gisela has collaborated with the Lancet Noncommunicable Diseases and Injuries (NCDIs) Poverty Commission by profiling risk factors to NCDIs across the poorest populations in the World, applying methodologies utilised by the Institute of Health Metrics (IHME) in its ongoing Global Burden of Disease (GBD) study. Gisela has also served as a Data Analyst at Oxford’s Clinical Trials Service Unit and Research Officer at the Oxford Poverty and Human Development Initiative (OPHI).
Gisela received her DPhil in Social Policy from Oxford in 2014, with a focus on modelling participation in conditional cash transfers.
Recent publications
The burden of bacterial antimicrobial resistance in the WHO Eastern Mediterranean Region 1990-2021: a cross-country systematic analysis with forecasts to 2050.
Journal article
EMR Antimicrobial Resistance Collaborators ., (2025), Lancet Public Health, 10, e955 - e970
A generalized LLMs framework to support public health financing through probabilistic predictions and uncertainty quantification.
Journal article
Guariso D. et al, (2025), Artif Intell Med, 168
Antimicrobial resistance burden landscape in Germany in 2019: a comparative country-level estimation.
Journal article
Meštrović T. et al, (2025), JAC Antimicrob Resist, 7
Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
Journal article
GBD 2021 Antimicrobial Resistance Collaborators ., (2024), Lancet, 404, 1199 - 1226